"Sumatriptan" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
| Descriptor ID |
D018170
|
| MeSH Number(s) |
D02.065.884.750 D02.886.590.700.750 D03.633.100.473.914.907
|
| Concept/Terms |
Sumatriptan- Sumatriptan
- 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
|
Below are MeSH descriptors whose meaning is more general than "Sumatriptan".
Below are MeSH descriptors whose meaning is more specific than "Sumatriptan".
This graph shows the total number of publications written about "Sumatriptan" by people in this website by year, and whether "Sumatriptan" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sumatriptan" by people in Profiles.
-
Shayan M, Eslami F, Amanlou A, Solaimanian S, Rahimi N, Rashidian A, Ejtemaei-Mehr S, Ghasemi M, Dehpour AR. Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or KATP channels inhibitors. Toxicol Appl Pharmacol. 2022 11 01; 454:116254.
-
Ala M, Ghasemi M, Mohammad Jafari R, Dehpour AR. Beyond its anti-migraine properties, sumatriptan is an anti-inflammatory agent: A systematic review. Drug Dev Res. 2021 11; 82(7):896-906.
-
Afshari K, Dehdashtian A, Haddad NS, Jazaeri SZ, Ursu DC, Khalilzadeh M, Haj-Mirzaian A, Shakiba S, Burns TC, Tavangar SM, Ghasemi M, Dehpour AR. Sumatriptan improves the locomotor activity and neuropathic pain by modulating neuroinflammation in rat model of spinal cord injury. Neurol Res. 2021 Jan; 43(1):29-39.
-
Eslami F, Rahimi N, Ostovaneh A, Ghasemi M, Dejban P, Abbasi A, Dehpour AR. Sumatriptan reduces severity of status epilepticus induced by lithium-pilocarpine through nitrergic transmission and 5-HT1B/D receptors in rats: A pharmacological-based evidence. Fundam Clin Pharmacol. 2021 Feb; 35(1):131-140.
-
Connelly NR, Parker RK, Rahimi A, Gibson CS. Sumatriptan in patients with postdural puncture headache. Headache. 2000 Apr; 40(4):316-9.